Contingency Management for the Treatment of Substance Use Disorders: Enhancing Access, Quality, and Program Integrity for an Evidence-Based Intervention
Stimulants represent a major and growing threat in the overdose crisis (1). Contingency management (CM) -- a psychosocial intervention that involves reinforcing abstinence from substances, as well as reinforcing other recovery-related behaviors -- is widely considered the most effective treatment for stimulant use disorder, and also has evidence as an effective treatment for alcohol, cannabis, and tobacco use disorders and as an effective adjunctive intervention to medications for opioid use disorder (MOUD) (2-4). While CM has been successfully implemented nationwide by the U.S. Department of Veterans Affairs (VA) and is permitted under several U.S. Department of Health and Human Services (HHS) grant programs and Medicaid demonstrations in California and Washington, it remains underutilized (5-8).
Download guide: https://aspe.hhs.gov/sites/default/files/documents/72bda5309911c29cd1ba3202c9ee0e03/contingency-management-sub-treatment.pdf